Status: current, Defined. Date: 30-Jun 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4407421000168111 | Xativa (cannabidiol 12.5 mg) sublingual wafer, 30 wafers, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4407431000168114 | Xativa 12.5 mg sublingual wafer, 30, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Xativa 12.5 mg sublingual wafer, 30, blister pack | Is a | Xativa 12.5 mg sublingual wafer, 30 | true | Inferred relationship | Some | ||
| Xativa 12.5 mg sublingual wafer, 30, blister pack | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Xativa 12.5 mg sublingual wafer, 30, blister pack | has container type | blister pack | true | Inferred relationship | Some | ||
| Xativa 12.5 mg sublingual wafer, 30, blister pack | has TP | Xativa | true | Inferred relationship | Some | ||
| Xativa 12.5 mg sublingual wafer, 30, blister pack | has TPUU | Xativa 12.5 mg sublingual wafer | true | Inferred relationship | Some | 1331119573 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Containered trade product pack reference set
FHIR